AlphaYou
Overview
Smart money at a glance
Filings to Oct 11, 2026Net buying: insiders sold $0 and bought $43K on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- +$43K netNet buying
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, latest quarter
- NoneNo large changes
Market overview
Fundamentals Oct 11- Open
- $4.09
- 52-wk high
- $5.52
- High
- $4.23
- 52-wk low
- $2.56
- Low
- $4.01
- Prev close
- $4.06
- Mkt cap
- $1.59B
- P/E
- 11.0x
- Volume
- 2.03M
- Fwd P/E
- 15.0x
- Beta
- 1.58
- P/S
- 7.4x
- P/B
- 1.8x
- Profit margin
- +25.9%
- Op margin
- +31.7%
- ROE
- +8.5%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about UROY filings
Are insiders buying or selling Uranium Royalty Corp (UROY) stock?
Net buying: insiders sold $0 and bought $43K of UROY stock on the open market in the 90 days to Oct 11, 2026, according to SEC Form 4 filings. The largest was Melbye, Scott (Chief Executive Officer), who bought $43K. The latest filing was on Jul 30, 2026.
Which members of Congress have traded UROY recently?
None. No member of Congress disclosed a UROY trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this UROY smart-money data?
This summary uses filings available on Oct 11, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position and insiders have been net buying.
What insiders are doing
Buys (1)
- MS
Melbye Scott
$43K
bought
How top traders are positioned
No tracked top-trader positions in UROY right now.
Live Hyperliquid positioning - not every stock is covered
Earnings
Earnings came in $0.05 a share above what analysts expected.
Last report
Sep 14, 2026
Period ending
Jul 31, 2026
Earnings per share
$0.05 expected
Revenue
No reported revenue on record
Previous reports
All values in USD| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / estimate | Rev. surprise |
|---|---|---|---|---|---|
| Jul 31, 2026 | Sep 14, 2026 | $0.10 / $0.05Alpha Vantage | +$0.05 beat | Unavailable | Unavailable |
| Apr 30, 2026 | Jul 15, 2026 | Unavailable | - | Unavailable | Unavailable |
| Jan 31, 2026 | Mar 10, 2026 | $0.01 / -$0.01Alpha Vantage | +$0.02 beat | Unavailable | Unavailable |
| Oct 31, 2025 | Dec 11, 2025 | $0.02 / -$0.01Alpha Vantage | +$0.03 beat | Unavailable | Unavailable |
| Jul 31, 2025 | Sep 11, 2025 | $0.01 / -$0.01Alpha Vantage | +$0.02 beat | Unavailable | Unavailable |
| Apr 30, 2025 | Jul 16, 2025 | -$0.01 / -$0.01Alpha Vantage | +$0.00 in line | Unavailable | Unavailable |
| Jan 31, 2025 | Mar 6, 2025 | -$0.01 / -$0.01Alpha Vantage | +$0.00 in line | Unavailable | Unavailable |
| Oct 31, 2024 | Dec 12, 2024 | -$0.00 / $0.01Alpha Vantage | -$0.01 miss | Unavailable | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue uses company releases and saved estimates.
What the street expects next
Financials
Is the business strong?
Fairly priced and profitable.
- Net margin
- 25.9%
- P/E
- 11.00
- Forward P/E
- 15.02
- Market cap
- $1.6B
Valuation
- P/S7.43
- P/B1.77
Quality
- Operating margin31.7%
- ROE8.5%
- ROA3.8%
Growth
- Beta1.58
Technicals
Price structure
This stock is under pressure.
Trend
Under pressure
15 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace